Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in t...

The Food and Drug Administration has lifted a clinical hold on one multiple myeloma trial for AbbVie's Venclexta after making several changes to the study protocols,...

An experimental biologic drug appeared to substantially delay the development of Type 1 diabetes in people at high risk for the chronic condition, surprising results...

Roche cancer drug Gazyva met its endpoint in a phase 2 lupus nephritis study, the company said. (Roche) One brand-new FDA approval and one trial win for its bloo...